Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

51 views
Visitors fromUSUS 54%·AUAU 32%·ININ 7%·GBGB 2%·FRFR 2%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

SBC Medical Group Co., Ltd. Sells Two Subsidiaries

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

On December 17, 2024, SBC Medical Group Holdings Incorporated (“SBC Medical”, or the “Company”), announced that its subsidiary, SBC Medical Group Co., Ltd. (hereinafter referred to as "SBCMG"), has decided to sell all shares of its subsidiaries, SBC Kijimadaira Resort Co., Ltd. (hereinafter referred to as "Kijimadaira") and Skynet Academy Co., Ltd. (hereinafter referred to as "SNA"), as outlined below. The decision to sell these subsidiaries was made to concentrate SBCMG's management resources on its core medical services business, in line with its strategy of prioritizing and focusing on key business areas.

The subsidiaries being sold operate in the following industries:

  • Kijimadaira: Ski resort operations
  • SNA: Flight training operations

The shares will be sold to a company wholly owned by Yoshiyuki Aikawa, the CEO of the Company. Since this transaction constitutes a related party transaction, it was deliberated and approved by the Company’s Board of Directors and Audit Committee. To ensure the fairness of the transaction, an independent third-party organization conducted a valuation. The results are as follows:

  1. The valuation of Kijimadaira shares reflects its negative equity, resulting in a nominal sale price.
  2. The valuation of SNA shares was determined based on the discounted cash flow (DCF) method. However, the transaction amount is not material in terms of financial reporting.

The impact of this transaction on the Company’s consolidated financial statements is expected to be minimal, with no significant changes to its financial position anticipated.

The transaction is expected to close by the end of December 2024, subject to standard closing conditions. SBC Medical remains committed to advancing its growth strategy centered on the medical services sector.

Contacts

SBC Medical Group Holdings Incorporated

Hikaru Fukui / Head of Investor Relations

e-mail: ir@sbc-holdings.com

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  244.21
+5.87 (2.46%)
AAPL  294.06
+4.70 (1.62%)
AMD  554.17
-26.74 (-4.60%)
BAC  58.26
+1.28 (2.25%)
GOOG  355.84
+2.51 (0.71%)
META  618.22
+54.93 (9.75%)
MSFT  387.70
+14.68 (3.94%)
NVDA  198.34
-1.75 (-0.87%)
ORCL  144.37
-2.18 (-1.49%)
TSLA  426.02
+5.42 (1.29%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.